Follow Us:
Cefalotin Exporter From India

Cefalotin

Cefalotin (also known as cephalothin) is a first-generation cephalosporin antibiotic used to treat serious bacterial infections caused by susceptible organisms, including certain infections of the respiratory tract, skin and soft tissues, bones, joints and urinary tract. It works by inhibiting bacterial cell-wall synthesis, leading to bacterial death. Cefalotin is available as a powder for injection and is administered intravenously or intramuscularly under medical supervision. It may also be used for perioperative infection prevention in selected clinical settings. Common side effects include nausea, diarrhoea, skin rash and injection-site discomfort. Serious risks include severe allergic reactions and antibiotic-associated colitis; caution is required in patients with beta-lactam allergies or impaired kidney function.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Cefalotin

Cefalotin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Cefalotin

Availability of Cefalotin

Delivery of Cefalotin

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Cefalotin.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Cefalotin.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cefalotin, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Cefalotin Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Cefalotin

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Cefalotin Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cefalotin, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Cefalotin

The export of Cefalotin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Cefalotin Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Cefalotin specifications, certificates of analysis, and other supporting documents required for Cefalotin export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Cefalotin export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Cefalotin regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Cefalotin documentation, labelling, Cefalotin manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Cefalotin Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Cefalotin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.